** Shares of medical device maker Baxter BAX.N rise 1.5% to $31.65
** BAX reports Q1 adj. profit of 55 cents per share, surpassing analysts' average estimate of 48 cents, according to data compiled by LSEG
** Co posts Q1 revenue of $2.63 billion, exceeding estimate of $2.59 billion
** BAX raises the lower end of its 2025 profit forecast range to $2.47 to $2.55 per share, compared with a prior view of $2.45 to $2.55
** Including session's moves, BAX stock up 9.02% YTD
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。